Strides Pharma Science has informed that it attached Press Release issued by the Company titled ‘Stelis Biopharma’s flagship facility receives EIR from the USFDA on the successful closure of its inspection specific to Drug-Device Combination Products’.
The above information is a part of company’s filings submitted to BSE.